Skip to main content
Premium Trial:

Request an Annual Quote

RainDance, IDT Partner on Consumables for Digital PCR Platform

NEW YORK (GenomeWeb News) – RainDance Technologies and Integrated DNA Technologies today said they will collaborate to develop consumables for use on the RainDrop Digital PCR System.

Financial and other terms of the deal were not disclosed.

The RainDrop system, launched by RainDance in March, generates up to 10 million picoliter-sized droplets per sample. Because each droplet encapsulates no more than a single molecule, researchers can "quickly determine the absolute number of droplets containing specific target DNA and compare that to the number of droplets with background, wild-type DNA," the firms said.

"We have achieved a new gold standard in sensitivity, quantitation, and multiplexing through enhancements in every aspect of system and reagent refinement," Rena McClory, marketing director for Digital PCR at RainDance Technologies, said in a statement. "We are pleased to be working with market leaders such as IDT on the development and broad availability of best-in-class reagents in support of our new RainDrop Digital PCR System."

"Digital PCR is redefining the science of directly quantifying and amplifying nucleic acids and will open the doors to an exciting era of new discoveries," Stephen Gunstream, SVP of marketing and strategy for IDT, added.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.